Skip to main content
. 2020 Nov 4;371:m3840. doi: 10.1136/bmj.m3840

Fig 1.

Fig 1

Trial profile. Of the 155 362 included patients, 79 127 were assigned to the 2014-15 pre-implementation period (37 579 patients in intervention hospitals, 41 548 in control hospitals) and 76 235 to the 2017-18 implementation period (37 468 and 38 767, respectively)